Exploring the Role of Positron Emission Tomography in Cardiovascular Imaging and Functional Assessment of the Heart
Cardiovascular diseases remain among the leading causes of mortality globally, and diagnostic innovation is key to early detection and effective management. Positron Emission Tomography has transformed cardiac imaging by offering detailed functional information about myocardial perfusion, viability, and metabolism.
Traditional imaging modalities provide structural insights into the heart’s anatomy, but PET goes further by revealing metabolic activity and blood flow patterns. Using radiotracers such as rubidium-82 and nitrogen-13 ammonia, PET enables quantitative measurement of myocardial blood flow, which is crucial in diagnosing coronary artery disease (CAD).
PET also excels in assessing myocardial viability. Following a heart attack, it helps determine whether damaged tissue remains metabolically active and could benefit from revascularization. This information is vital for cardiologists to make informed decisions about bypass surgery or stenting.
Compared to SPECT, PET offers superior image resolution, faster acquisition, and lower radiation exposure. Quantitative PET perfusion imaging allows absolute measurement of blood flow rather than relative comparisons, providing greater diagnostic accuracy.
The emergence of hybrid PET/CT and PET/MRI technologies has further enhanced cardiac imaging. PET/CT combines metabolic and anatomical data, while PET/MRI provides high-contrast soft-tissue visualization without additional radiation. These systems are particularly useful in pediatric and congenital heart disease assessments.
Another important area is cardiac inflammation and infection imaging. PET identifies areas of inflammatory activity in conditions such as myocarditis, endocarditis, and cardiac sarcoidosis. This non-invasive visualization aids in early diagnosis and therapeutic monitoring.